Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:diabetes
|
| gptkbp:administered_by |
subcutaneous injection
|
| gptkbp:approves |
gptkb:2020
gptkb:United_States |
| gptkbp:chemical_formula |
C257 H383 N65 O77 S
|
| gptkbp:clinical_trial |
ongoing
|
| gptkbp:developed_by |
gptkb:University_of_Chicago
|
| https://www.w3.org/2000/01/rdf-schema#label |
GIK-1
|
| gptkbp:mechanism_of_action |
stimulates glucose uptake
|
| gptkbp:side_effect |
hypoglycemia
|
| gptkbp:used_for |
treatment of diabetes
|
| gptkbp:weight |
5808.4 g/mol
|
| gptkbp:bfsParent |
gptkb:RD-0210_engine
gptkb:RD-0250_engine gptkb:RD-500_rocket_engine |
| gptkbp:bfsLayer |
7
|